These days, the United States pharmaceutical market only has 3 major weight loss medications available: Xenical (orlistat), Meridia (sibutramine), and Phentermine. Obese patients and many doctors alike are hoping for brand new and better fat reduction pills to emerge. 2 brand new fat reduction pills at present being made and studied in Europe are rimonabant (Acomplia) as well as taranabant.
Rimonabant seemed like a promising brand new fat reduction pill, but the FDA became worried about some serious psychiatric side effects like depression and suicidal tendencies. Taranabant, so much, is showing fewer as well as milder unwanted side effects despite the fact that both chemical based drugs work similarly and tea burn directions - www.islandssounder.com - generate comparable weight loss.
Both new fat reduction pills greatly influence the receptors in the body's system which adjusts things such as energy level, food intake, metabolism and in addition fear and anxiety. Up to now, the reason for the differences in side effects is unknown.
Dosage may well be a factor. Less taranabant is required to produce similar weight-loss. Taranabant and rimonabant likewise have small differences in how they communicate with the receptors. It's unclear for now why there are fewer negative effects in a single new weight loss pill and not the other.
Rimonabant, or Acomplia, is right now offered in Europe, but it doesn't look as though this new fat reduction pill will make the debut of its in the Country for awhile. Merck, the pharmaceutical company acquiring taranabant, seems hopeful that they will be able to file for FDA endorsement in the summer months of 2008. Still, the trials aren't over and yes it might be awhile before this new weight reduction pill can be obtained stateside.
For a lot of obese patients, hope in the type of an innovative, effective weight-loss pill can't come soon enough. It's extraordinary that with all the pharmaceuticals out on the market that you will find only 3 approved weight loss pills out there.
The trouble is which the part of obesity which can be manipulated by the individual is directly related to human behavior. The component of obesity that can't be controlled isn't entirely understood.
We are left in a conundrum of sorts. In case a person is obese as a result of lack of proper exercise as well as nutrition, he or perhaps she might be helped, but mainly if that person is prepared to help him or herself. If the individual has in earnest made an effort to lose weight and cannot, than medical intervention may be necessary. Regrettably, every new weight reduction pill that comes about seems to have potentially detrimental side effects. The FDA cannot be blamed for not letting the sale of drugs like Rimonabant. The responsibility of the FDA is protecting the public from potentially damaging substances. In light of the deaths that came about through the usage of Fen phen, the FDA has reason to be gun shy.